Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Evidence That Two Alkyl Ester Quaternary Ammonium Compounds Lack Substantial Human Skin-Sensitizing Potential

Jowsey, Ian R.; Kligman, Albert M.; White, Ian R.; Goossens, An; Basketter, David A.

doi: 10.2310/6620.2007.06036
STUDY
Buy

Background: Alkyl ester quaternary ammonium compounds (ester quats) are used extensively in fabric rinse conditioners. It is important to document in the literature the outcome of historical studies that were performed to assess the risk of adverse skin effects associated with their use.

Objectives: (1) To document the outcomes of historical studies performed to evaluate the skin sensitizing potential of two ester quats (the di-[hardened tallow fatty acid] ester of 2,3-dihydroxypropyl-trimethyl ammonium chloride [HEQ] and the dialkyl ester of triethanol ammonium methyl sulfate [TEA-Quat]) and (2) to demonstrate that these ester quats lack marked skin-sensitizing potential in humans, such that they do not present a risk of contact allergy for consumers who use fabric rinse conditioners.

Methods: Each material was assessed in the human maximization test in a panel of 25 volunteers. Diagnostic patch testing was also performed with each material in a population of 239 patients undergoing routine patch testing for suspected allergic contact dermatitis. These data are also considered in the context of an exposure-based quantitative risk assessment.

Results: Neither HEQ nor TEA-Quat was found to cause skin sensitization under the conditions of the human maximization test. No evidence of contact allergy to the materials was found among the relatively small population assessed by diagnostic patch testing.

Conclusions: This study provides evidence that HEQ and TEA-Quat lack substantial skin-sensitizing potential in humans. Taken together with similar data for other ester quats, it suggests that compounds in this class are unlikely to be significant human contact allergens.

From the Unilever Safety and Environmental Assurance Centre, Colworth Park, Sharnbrook, Bedfordshire, UK; the Department of Dermatology, University of Pennsylvania, Philadelphia, PA; St. John's Institute of Dermatology, St. Thomas' Hospital, London, UK; and the Department of Dermatology, K.U. Leuven University Hospital, Leuven, Belgium.

Address reprint requests to Dr. Ian R. Jowsey, Unilever Safety and Environmental Assurance Centre, Colworth Park, Sharnbrook, Bedfordshire MK44 1LQ, UK. E-mail:ian.jowsey@unilever.com

©2007American Contact Dermatitis Society, All Right Reserved
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website